- You are here:
-
Home
- News
News
- Details
- Category: POZ.com
Here are the researchers who will lead the four networks of HIV trials and what each network will focus on.
- Details
- Category: POZ.com
The 90-90-90 HIV targets expire at the end of 2020. Bob Leahy looks at what comes next and what role people living with HIV can play.
- Details
- Category: POZ.com
While receiving a lifetime achievement award, the infectious disease expert shares memories and insights.
- Details
- Category: POZ.com
UNAIDS hopes nations will follow the lead of a number of sub-Saharan African countries that are gaining control of their HIV epidemics.
- Details
- Category: POZ.com
How many people have HIV in the United States? In the world? Here’s a primer on basic statistics.
- Details
- Category: POZ.com
So concluded a pooled analysis of 27 studies mostly conducted in higher income nations.
- Details
- Category: POZ.com
Plan now to watch Black theater and AIDS films, listen to top scientists, and watch 1990s videos—all on December 1.
- Details
- Category: POZ.com
The company also has plans to study monthly islatravir’s efficacy as HIV prevention among men who have sex with men.
- Details
- Category: POZ.com
A study looked at the fat composition of people who switched their antiretrovirals to include an integrase inhibitor.
- Details
- Category: POZ.com
Long-acting injectable cabotegravir for HIV prevention could hit the market for men and women in early 2022.
- Details
- Category: POZ.com
The study in Vietnam examined the effects of an intervention based in cognitive behavioral and motivational enhancement therapy.
Subcategories
Fundraisers Article Count: 2
Health Article Count: 4
HIV / AIDS Article Count: 4
Partners Article Count: 285
POZ.com Article Count: 284
POZ Stories Article Count: 11
Page 3 of 25
- You are here:
-
Home
- News